 CAMBRIDGE, Mass., Nov. 03, 2020 GLOBE NEWSWIRE -- Solid Biosciences Inc. Nasdaq: SLDB, a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy Duchenne, today announced that it will release third quarter 2020 financial results before the market opens on Thursday, November 5, 2020. Management will host a conference call on the same date beginning at 8:30 a.m. ET to discuss the Companys financial results and recent business developments. 